ir.omnicell.com
Investor Relations | Omnicell, Inc.The Investor Relations website contains information about Omnicell, Inc.'s business for stockholders, potential investors, and financial analysts.
http://ir.omnicell.com/
The Investor Relations website contains information about Omnicell, Inc.'s business for stockholders, potential investors, and financial analysts.
http://ir.omnicell.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
0.3 seconds
16x16
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
34
SITE IP
104.91.183.85
LOAD TIME
0.266 sec
SCORE
6.2
Investor Relations | Omnicell, Inc. | ir.omnicell.com Reviews
https://ir.omnicell.com
The Investor Relations website contains information about Omnicell, Inc.'s business for stockholders, potential investors, and financial analysts.
ir.omnicell.com
Omnicell Events & Presentations
http://ir.omnicell.com/events.cfm
Details on upcoming events are not yet available. Please click here. To be notified of all upcoming events. Jul 28, 2016. Omnicell 2nd Quarter 2016 Earnings Call. May 5, 2016. Omnicell, Inc. at Deutsche Bank 41st Annual Health Care Conference. Apr 28, 2016. Omnicell 1st Quarter 2016 Earnings Call. Feb 4, 2016. Omnicell 4th Quarter 2015 Earnings Call. Dec 1, 2015. 27th Annual Piper Jaffray Health Care Conference. Oct 29, 2015. Omnicell 3rd Quarter 2015 Earnings Call. Omnicell to Acquire Aesynt Presentation.
Omnicell Printed Materials
http://ir.omnicell.com/printed-materials.cfm
To receive printed material by postal mail, please complete the following form. Fixed Income Analyst (sell-side). Fixed Income Analyst (buy-side). Portfolio Manager (Fixed Income). Holy See (Vatican City). Saint Kitts And Nevis. Saint Vincent and Grenadines. Turks And Caicos Islands. Virgin Islands (U.S.). UPS Next Day Air. Required for express delivery. Listen to audio version. Type in number *. I am interested in receiving investor relations notifications. Omnicell to Acquire Aesynt. 3709 - 37.70.
Omnicell
http://ir.omnicell.com/eventdetail.cfm?EventID=163143
Details on this event are not available. Omnicell to Acquire Aesynt. 3709 - 37.70. 2506 - 40.24. 4:00 PM ET on Aug 26, 2016. Delayed at least 20 minutes. Annual Reports and Proxies. Central Pharmacy Automation Systems. Hospital Supply Chain Management. Enter Search Keywords and Submit.
Omnicell Annual Reports and Proxies
http://ir.omnicell.com/annuals-proxies.cfm
Annual Reports and Proxies. Annual Reports and Proxies. File is in Briefcase. 2015 Annual Report on Form 10K. File is in Briefcase. Add file to Briefcase. Omnicell to Acquire Aesynt. 3709 - 37.70. 2506 - 40.24. 4:00 PM ET on Aug 26, 2016. Delayed at least 20 minutes. Annual Reports and Proxies. Central Pharmacy Automation Systems. Hospital Supply Chain Management. Enter Search Keywords and Submit.
Omnicell Financials & Filings
http://ir.omnicell.com/financials.cfm
Here you will find a summary of Omnicell, Inc.'s latest financial information. Second Quarter 2016 Financial Results. Omnicell Achieves Record Revenue in the Second Quarter 2016. Omnicell 2nd Quarter 2016 Earnings Call. Q2 16 Complementary Summary of Earnings Release with Tables. File is in Briefcase. File is in Briefcase. File is in Briefcase. Apr 18, 2016. File is in Briefcase. Apr 20, 2015. File is in Briefcase. Feb 26, 2016. File is in Briefcase. Mar 30, 2015. File is in Briefcase. Aug 5, 2016.
TOTAL PAGES IN THIS WEBSITE
20
Old Republic International Corporation - Investor Relations Home
 Dividends and Splits.  Events and Webcasts.  Policy Re: Investors/Stakeholders' Information Requests. Old Republic International Corporation (Old Republic) is among the nation's 50 largest publicly held insurance organizations, with a substantial interest in major segments of the industry. The Company is primarily a commercial lines underwriter, serving many of America's leading industrial and financial services companies as valued.Â. Phoenix Aviation Managers Is Now Old Republic Aerospace.
نظارت - NordFX.com | المپیک DemoCup
شروع 08/08/2016. پایان 19/08/2016. حساب مجازی، جوایز واقعی. مسابقات از کشور و تیم. مسابقات از کشور و تیم. 3 مجموعه از جوایز در یک تیم و به ثمر رساند فردی. جمع جایزه صندوق باعث 23،100. ۳ معامله گران برتر. جزاير تورکس و کايکوس. جزاير هرد و مک دونالد. جزاير والیس و فوتونا. جزایر کوچک حاشیه ای ایالات متحده. جمهوری دموکراتیک خلق لائوس. جمهوری دموکراتیک خلق کره. سنت وینست و گرنادین. سنت کیت و نویس. مستملکات انگلستان در اقيانوس هند. مقدونیه، جمهوری یوگسلاوی سابق. واتیکان (ایالت مستقل واتیکان). مسابقه در 2016/08...
OMA Airports - Investor Relations
San Luis Potosí. Ciudad Juárez Plaza. San Luis Potosí Plaza. Why Invest in OMA. Why invest in OMA. Earnings Reports and Conference Calls. Best Corporate Practices Code. We value your opinion. OMA- creating value for our shareholders. Feb 22, 2018. OMA announces Fourth Quarter and Full Year 2017 Operational and Financial Results More. Nov 16, 2017. OMA announces resignation of Chief Financial Officer More. Oct 17, 2017. OMA announces Third Quarter 2017 Operational and Financial Results More. Apr 6, 2018.
Investor Relations « Omega Protein
News & Media. Science & Innovation. Annual Reports and Proxy Statements. Day High: 15.75. Day Low: 15.24. Prior Close: 15.33. Aug 7, 2015. Delayed 20 min., by eSignal. At Omega Protein, we strive to be a respected leader in every market we serve by providing customers with premium, sustainable products for a healthier world. In pursuit of this mission, we are committed to maximizing shareholder value through the introduction of new and innovative products. Aug 5, 2015. Jul 30, 2015. Day High: 15.75.
Omnicare : Investors
Omnicare, Inc., a Fortune 500 company based in Cincinnati, Ohio, provides comprehensive pharmaceutical services to patients and providers across the United States. As the market-leader in professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other chronic care settings, Omnicare leverages its unparalleled clinical insight into the geriatric market along with some of the industry's most innovative technological capabilities to the benefit o...
Investor Relations | Omnicell, Inc.
Skip to main navigation. Omnicell, Inc., is a leading provider of solutions targeting patient safety and operational efficiency in healthcare facilities. From the point at which a medication arrives at the receiving dock to the time it is administered, Omnicell systems store it, package it, bar code it, order it, issue it, and charge it. Mar 27, 2018. Mercyhealth Adopts Omnicell's XR2 Automated Central Pharmacy System to Enhance Patient Safety. Mar 22, 2018. View all press releases. Mar 27, 2018. IvSTATI...
Oncobiologics - Investor Overview
Regulatory and Clinical Development. GMP Manufacturing Facility Tour. Oncobiologics is a clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics. Our current focus is on technically challenging and commercially attractive monoclonal antibodies (mAbs), in the disease areas of immunology and oncology. Our strategy is to leverage our BioSymphony Platform to cost-effectively develop these biosimilars on an accelera...
OncoGenex Pharmaceuticals, Inc. - Investor Relations
Scientific Publications and Presentations. Scientific Publications and Events. Aug 4, 2016. OncoGenex Second Quarter 2016 Conference Call. Aug 16, 2016. Oct 13, 2016. OncoGenex ENSPIRIT Trial Conference Call. Exploring New Compounds to Meet the Challenge of Cancer Treatment Resistance. Phase 2 in bladder, lung, pancreatic and prostate cancers. Role of Hsp27 and Apatorsen (OGX-427). Aug 1, 2017. Achieve Life Sciences Announces Closing of Merger with OncoGenex Pharmaceuticals. Jun 13, 2017. May 15, 2017.
Overview
Media & Events. Advancing a lead portfolio of gene therapies for cancer. Platform focused on reversing tumor immune suppression. Phase II clinical programs focused on addressing unmet need of T-cell poor tumors. Clinical data demonstrates proof of concept of the technology. Rapid preclinical development platform. OncoSec Announces Strategic Relocation Of Office And Laboratories. Mar 20, 2018. Jan 31, 2018. Sign up for email alerts. Be the first to receive breaking news.
Overview - Oncothyreon
Annual Reports and Proxy. We are committed to serving the best interests of our shareholders. If you require assistance or have questions regarding the key shareholder information and financial reports available here please contact. 027 (- 7.56%). 4:00 PM ET on Aug 7, 2015. Delayed at least 20 minutes. Aug 6, 2015. Oncothyreon Reports Second Quarter 2015 Financial Results. Jul 30, 2015. Oncothyreon Announces Second Quarter 2015 Financial Results Conference Call. View all recent releases ».
IR Overview :: One Horizon Group, Inc. (OHGI)
Carrier Products and Services. One Horizon's Carrier Technology. Billing and Provisioning Platform. Rapid Deployment and Simple Integration. The Aishuo Mobile App. Enterprise Products and Services. One Horizon's Enterprise Technology. Rapid Deployment and Simple Integration. Limitations of Mobile VoIP. Horizon Library For Developers. One Horizon Group, Inc. (NASDAQ: OHGI). SeeThru Equity Research Report. Outstanding: 32,921,533. As of May 15, 2015). One Horizon Group, Inc. Tierney Building - T1017.
SOCIAL ENGAGEMENT